414PDPhase I study of the CTLA-4 inhibitor MK-1308 in...

Annals of Oncology 2018 / 10 Vol. 29; Iss. suppl_8

414PDPhase I study of the CTLA-4 inhibitor MK-1308 in combination with pembrolizumab in patients with advanced solid tumors

Cho, B C, Perets, R, Bar, J, Ahn, M-J, Kim, D-W, Yoh, K, Nagrial, A, Spigel, D R, Lee, D H, Gutierrez, M, Kotasek, D, Siddiqi, S, Chain, A, Butts, B D, Zhang, Y, Li, X, Cyrus, J, Tse, A, Altura, R A,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
29
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdy279.402
Date:
October, 2018
File:
PDF, 76 KB
english, 2018
Conversion to is in progress
Conversion to is failed